DK162896C - Fremgangsmaade til oprensning af factor viii:c samt farmaceutisk praeparat indeholdende denne - Google Patents

Fremgangsmaade til oprensning af factor viii:c samt farmaceutisk praeparat indeholdende denne

Info

Publication number
DK162896C
DK162896C DK575184A DK575184A DK162896C DK 162896 C DK162896 C DK 162896C DK 575184 A DK575184 A DK 575184A DK 575184 A DK575184 A DK 575184A DK 162896 C DK162896 C DK 162896C
Authority
DK
Denmark
Prior art keywords
factor viii
procedure
pharmaceutical preparation
preparation containing
cleaning factor
Prior art date
Application number
DK575184A
Other languages
Danish (da)
English (en)
Other versions
DK162896B (da
DK575184A (da
DK575184D0 (da
Inventor
Godfrey A Amphlett
Michael E Hrinda
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of DK575184D0 publication Critical patent/DK575184D0/da
Publication of DK575184A publication Critical patent/DK575184A/da
Publication of DK162896B publication Critical patent/DK162896B/da
Application granted granted Critical
Publication of DK162896C publication Critical patent/DK162896C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
DK575184A 1983-12-05 1984-12-04 Fremgangsmaade til oprensning af factor viii:c samt farmaceutisk praeparat indeholdende denne DK162896C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/557,805 US4508709A (en) 1983-12-05 1983-12-05 Process for purifying factor VIII:C
US55780583 1983-12-05

Publications (4)

Publication Number Publication Date
DK575184D0 DK575184D0 (da) 1984-12-04
DK575184A DK575184A (da) 1985-06-06
DK162896B DK162896B (da) 1991-12-23
DK162896C true DK162896C (da) 1992-05-11

Family

ID=24226953

Family Applications (1)

Application Number Title Priority Date Filing Date
DK575184A DK162896C (da) 1983-12-05 1984-12-04 Fremgangsmaade til oprensning af factor viii:c samt farmaceutisk praeparat indeholdende denne

Country Status (19)

Country Link
US (1) US4508709A (xx)
EP (1) EP0144957B1 (xx)
JP (1) JPS60136518A (xx)
KR (1) KR850004593A (xx)
AT (1) ATE60996T1 (xx)
AU (1) AU569129B2 (xx)
CA (1) CA1248449A (xx)
DE (1) DE3484179D1 (xx)
DK (1) DK162896C (xx)
ES (1) ES538912A0 (xx)
FI (1) FI844804L (xx)
IE (1) IE57644B1 (xx)
IL (1) IL73734A (xx)
IN (1) IN162586B (xx)
MX (1) MX7552E (xx)
NO (1) NO167627C (xx)
NZ (1) NZ210427A (xx)
SG (1) SG14992G (xx)
ZA (1) ZA849434B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614795A (en) * 1982-08-05 1986-09-30 University Of Rochester Deglycosylated Human Factor VIII:C
DE3481109D1 (de) * 1983-05-09 1990-03-01 Novo Nordisk As Antihaemophilie-faktor-viii-konzentrat und dessen herstellungsverfahren.
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
GB2178533B (en) * 1985-07-22 1989-07-19 Asahi Chemical Ind Analytical method of enzyme precursors and device therefor
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3826792C1 (xx) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
ES2053684T3 (es) * 1988-11-05 1994-08-01 Octapharma Ag Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
JPH0427865A (ja) * 1989-12-21 1992-01-30 Kurita Water Ind Ltd 血液凝固因子用分離剤およびその製造方法
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Also Published As

Publication number Publication date
DK162896B (da) 1991-12-23
DK575184A (da) 1985-06-06
FI844804A0 (fi) 1984-12-05
IL73734A0 (en) 1985-03-31
EP0144957A3 (en) 1987-09-30
KR850004593A (ko) 1985-07-25
SG14992G (en) 1992-04-16
CA1248449A (en) 1989-01-10
ZA849434B (en) 1985-07-31
ES8600690A1 (es) 1985-11-01
NZ210427A (en) 1988-09-29
IE843105L (en) 1985-06-05
AU3598284A (en) 1985-06-13
NO167627B (no) 1991-08-19
IL73734A (en) 1989-09-28
IE57644B1 (en) 1993-02-10
NO167627C (no) 1991-11-27
ATE60996T1 (de) 1991-03-15
NO844837L (no) 1985-06-06
JPH0535159B2 (xx) 1993-05-25
AU569129B2 (en) 1988-01-21
IN162586B (xx) 1988-06-11
EP0144957A2 (en) 1985-06-19
US4508709A (en) 1985-04-02
FI844804L (fi) 1985-06-06
MX7552E (es) 1989-09-25
DK575184D0 (da) 1984-12-04
EP0144957B1 (en) 1991-02-27
ES538912A0 (es) 1985-11-01
JPS60136518A (ja) 1985-07-20
DE3484179D1 (de) 1991-04-04

Similar Documents

Publication Publication Date Title
DK162896C (da) Fremgangsmaade til oprensning af factor viii:c samt farmaceutisk praeparat indeholdende denne
IT1142464B (it) Procedimento per il frazionamento di soluzioni di misugli proteici
IT8067318A0 (it) Procedimento per la produzione di preparati di nerofumo contenenti acqua
DK32982A (da) Terapeutisk nyttige tetralinderivater
DK173883D0 (da) Substituerede 8-phenylxanthiner
DK357880A (da) Fremgangsmaade til rensning af humant vaeksthormon
GB8824249D0 (en) Analysis of organic compounds in chromatography
FR2487642B2 (fr) Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
GB2015531B (en) Purification of bordetella proteins by chromatography
DE3678633D1 (de) Verfahren zur reinigung vom humanen tumornekrosefaktor.
DK436982A (da) Fremgangsmaade til forbedring af kvaliteten af valleprotein
RO85557A (ro) Procedeu pentru prepararea carbonatilor de alchilen
IT7951080A0 (it) Procedimento per la preparazione di acetonitrili sostituiti
RO88687A (ro) Procedeu pentru recuperarea zaharozei
IT1126840B (it) Procedimento per aumentare la resistenza all'acqua di preparati per cromatografia
YU111685A (en) Process for obtaining of rose liquid using dry distillation
IT7847691A0 (it) Procedimento per il recupero di caprolattame
IT1179298B (it) Sistema per eseguire sottopiedi per calzature
BE880619A (fr) Procede de preparation de n-chloroimides
IT1165960B (it) Metodo per la preparazione di composti polimerizzabili di triorgano stagno
ES550518A0 (es) Nuevo metodo de obtencion del trans-1-metil-1-(5-hidroxi-4- metil-3-ciclohexenil)etanol
BG37188A1 (en) Method for analysis of pyrazolonic derivatives by high- efficiency liquid chromatography
IT1097151B (it) Metodo per la preparazione di composti nitroso-aromatici
RO89256A2 (ro) Procedeu de preparare a clorurii de p-clorbenzhidril
RO80866A2 (ro) Procedeu pentru cateterizarea venelor

Legal Events

Date Code Title Description
PUP Patent expired